Eur. J. Cancer

376 (PB364): Targeting TGF-β signaling components to ameliorate Palbociclib resistance in breast cancer

Ali M, Itoh Y, Heldin CH, Moustakas A

Eur. J. Cancer 211 (-) 114889 [2024-10-00; online 2024-10-00]

European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment.

Derksen JWG, Warren GW, Jordan K, ..., Koopman M, May AM

Eur. J. Cancer 138 (-) 99-108 [2020-10-00; online 2020-08-29]

The integrated stress response exposes a therapeutic vulnerability in KRAS driven lung cancer

Ghaddar N, Wang S, Woodvine B, ..., Le Quesne J, Koromilas A

Eur. J. Cancer 138 (-) S23 [2020-10-00; online 2020-10-00]

Breast cancer in young women and prognosis: How important are proliferation markers?

Fredholm H, Magnusson K, Lindström LS, ..., Frisell J, Fredriksson I

Eur. J. Cancer 84 (-) 278-289 [2017-10-00; online 2017-08-29]

Affiliated researcher

Menopausal hormone therapy and cancer risk: An overestimated risk?

Simin J, Tamimi R, Lagergren J, Adami HO, Brusselaers N

Eur. J. Cancer 84 (-) 60-68 [2017-10-00; online 2017-08-04]

Affiliated researcher